These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. TREATMENT OF ADVANCED CANCER WITH 5-FLUOROURACIL. HURLEY JD Acta Unio Int Contra Cancrum; 1964; 20():363-5. PubMed ID: 14151930 [No Abstract] [Full Text] [Related]
8. FURTHER CLINICAL COMPARISON BETWEEN 5-FLUOROURACIL (5-FU) AND 5-FLUORO-2' -DEOXYURIDINE (5-FUDR). ANSFIELD FJ; CURRERI AR Cancer Chemother Rep; 1963 Oct; 32():101-5. PubMed ID: 14088828 [No Abstract] [Full Text] [Related]
9. The use of parenteral 5-fluorouracil in solid tumours. A preliminary report. Chakravorty RC; Sarkar SK; Mukerji B J Indian Med Assoc; 1969 Jan; 52(1):27-31. PubMed ID: 5801452 [No Abstract] [Full Text] [Related]
10. N-ISOPROPYL-ALPHA-(2-METHYLHYDRAZINO)-P-TOLUAMIDE, HYDROCHLORIDE (NSC-77213) IN TREATMENT OF SOLID TUMORS. BRULE G; SCHLUMBERGER JR; GRISCELLI C Cancer Chemother Rep; 1965 Feb; 44():31-8. PubMed ID: 14294810 [No Abstract] [Full Text] [Related]
11. EXPERIMENTS IN HOST RESISTANCE TO CANCER (IN HUMAN SUBJECTS). MURRAY G Am J Surg; 1965 Jun; 109():763-4. PubMed ID: 14283336 [No Abstract] [Full Text] [Related]
12. THE PREVALENCE RATE OF MORBIDITY FROM CANCER IN A DEFINED POPULATION. BARCLAY TH Acta Unio Int Contra Cancrum; 1964; 20():620-2. PubMed ID: 14165382 [No Abstract] [Full Text] [Related]
13. Clinical experience with a new alkylating agent, azetepa, in a variety of solid tumors. CHOY DS; STYLIANOU S Cancer Chemother Rep; 1962 Oct; 23():47-50. PubMed ID: 14021063 [No Abstract] [Full Text] [Related]
14. [DIFFERENTIATED DOSES IN RELATION TO THE GREATER OR LESSER RADIOSENSITIVITY OF THE VARIOUS ZONES OF A SINGLE NEOPLASM]. MARTINENGHI C; CASTELLANO E; TAROLO GL Minerva Radiol Fisioter Radiobiol; 1963 Sep; 14():370-7. PubMed ID: 14085058 [No Abstract] [Full Text] [Related]
15. [OBSERVATIONS ON THE BEHAVIOR OF HEMATIC CRASIS IN 134 PATIENTS SUBJECTED TO CHEMOTHERAPEUTIC TREATMENT WITH CYCLOPHOSPHAMIDE FOR GENITAL NEOPLASMS]. FONTANA-DONATELLI G; DAMBROSIO F Ann Ostet Ginecol; 1963 Nov; 85():929-40. PubMed ID: 14099536 [No Abstract] [Full Text] [Related]
16. REGRESSION OF METASTATIC HEPATOMEGALY FROM MAMMARY CARCINOMA. CYTOTOXIC COMBINATION CHEMOTHERAPY WITH 5-FU. GREENSPAN EM N Y State J Med; 1964 Oct; 64():2442-9. PubMed ID: 14209557 [No Abstract] [Full Text] [Related]
17. TREATMENT OF MALIGNANT NEOPLASMS OF THE GASTROINTESTINAL TRACT WITH A COMBINATION OF 5-FLUOROURACIL AND RADIATION: A RANDOMIZED DOUBLE-BLIND STUDY. CHILDS DS; MOERTEL CG; HOLBROOK MA; REITEMEIER RJ; COLBY MY Radiology; 1965 May; 84():843-8. PubMed ID: 14282693 [No Abstract] [Full Text] [Related]
18. THE DIAGNOSIS OF CANCER WITH RADIOISOTOPIC TECHNIQUES. ACKERMAN NB Surg Gynecol Obstet; 1964 Jun; 118():1333-45. PubMed ID: 14177854 [No Abstract] [Full Text] [Related]
19. [DRUG-INDUCED EXANTHEMA IN THE CYTOSTATIC TREATMENT OF GENITAL CARCINOMA IN WOMEN]. BILLICH R; WILLMES H Geburtshilfe Frauenheilkd; 1964 Jun; 24():497-506. PubMed ID: 14237970 [No Abstract] [Full Text] [Related]
20. [PROTEOANABOLIC MEDICATION IN THE AREA OF ANTIBLASTIC GYNECOLOGIC THERAPY]. VARIATI G Ann Ostet Ginecol; 1964 Sep; 86():742-50. PubMed ID: 14263116 [No Abstract] [Full Text] [Related] [Next] [New Search]